Emerging Pharma Leadership Awards - Elizabeth Mutisya

October 19, 2009

Elizabeth Mutisya, VP, US Medical Affairs, CMO, Solvay PharmaceuticalsDownload Adobe Flash Player

“We need to do a better job of delineating the value our industry provides in addressing medical problems. Health economics allows us to better quantify the benefits of our solutions to patient outcomes, health-related quality of life, and individuals involved in patient care.” Listen to the Podcast for more coverage.

Related Content:

News